Cleared Traditional

LOW VISION ENHANCEMENT SYSTEM (LVES) (K910124) - FDA 510(k) Clearance

Class I Ophthalmic device.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1991
Decision
89d
Days
Class 1
Risk

K910124 is an FDA 510(k) clearance for the LOW VISION ENHANCEMENT SYSTEM (LVES). Classified as Aid, Vision, Electronic, Battery-powered (product code HPG), Class I - General Controls.

Submitted by Triangle Investments (Baltimore, US). The FDA issued a Cleared decision on April 10, 1991 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5900 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Triangle Investments devices

Submission Details

510(k) Number K910124 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 11, 1991
Decision Date April 10, 1991
Days to Decision 89 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 110d · This submission: 89d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HPG Aid, Vision, Electronic, Battery-powered
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 886.5900
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.